Maulin Mukeshchandra Patel
| Title | Fellow,Postdoctoral Research |
|---|
| Institution | University of Oklahoma Health Sciences Center |
|---|
| Department | Cell Biology |
|---|
| Address | BRC 262
975 NE 10th St
Oklahoma City OK 73104
|
|---|
| vCard | Download vCard |
|---|
|
|
|
Bibliographic
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Elechalawar CK, Rao G, Gulla SK, Patel MM, Frickenstein A, Means N, Roy RV, Tsiokas L, Asfa S, Panja P, Rao C, Wilhelm S, Bhattacharya R, Mukherjee P. Correction to "Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation". ACS Nano. 2024 Mar 26; 18(12):9242.
PMID: 38465974.
-
Patel MM, Gerakopoulos V, Petsouki E, Zimmerman KA, Tsiokas L. Nephronophthisis-associated FBW7 mediates cyst-dependent decline of renal function in ADPKD. bioRxiv. 2024 Mar 02.
PMID: 38464230; PMCID: PMC10925305.
Citations:
-
Houser JS, Patel M, Wright K, Onopiuk M, Tsiokas L, Humphrey MB. The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation. Blood Cells Mol Dis. 2023 09; 102:102760.
PMID: 37267696.
Citations: Fields:
Translation:
AnimalsCells
-
Elechalawar CK, Rao G, Gulla SK, Patel MM, Frickenstein A, Means N, Roy RV, Tsiokas L, Asfa S, Panja P, Rao C, Wilhelm S, Bhattacharya R, Mukherjee P. Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation. ACS Nano. 2023 May 02.
PMID: 37129853.
Citations: Fields:
Translation:
HumansCells
-
Chaaban H, Patel MM, Burge K, Eckert JV, Lupu C, Keshari RS, Silasi R, Regmi G, Trammell M, Dyer D, McElroy SJ, Lupu F. Early Antibiotic Exposure Alters Intestinal Development and Increases Susceptibility to Necrotizing Enterocolitis: A Mechanistic Study. Microorganisms. 2022 Feb 27; 10(3).
PMID: 35336095.
-
Patel MM, Tsiokas L. Insights into the Regulation of Ciliary Disassembly. Cells. 2021 11 01; 10(11).
PMID: 34831200.
Citations:
9 Fields:
Translation:
HumansAnimalsCells
-
Dogra S, Neelakantan D, Patel MM, Griesel B, Olson A, Woo S. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism. Mol Cancer Res. 2021 09; 19(9):1534-1545.
PMID: 34172534.
Citations:
14 Fields:
Translation:
HumansAnimalsCells
-
Lupu C, Patel MM, Lupu F. Insights into the Functional Role of ADTRP (Androgen-Dependent TFPI-Regulating Protein) in Health and Disease. Int J Mol Sci. 2021 Apr 24; 22(9).
PMID: 33923232.
Citations:
8 Fields:
Translation:
Humans
-
Ziegler J, Zalles M, Smith N, Saunders D, Lerner M, Fung KM, Patel M, Wren JD, Lupu F, Battiste J, Towner RA. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment. Am J Nucl Med Mol Imaging. 2019; 9(1):93-109.
PMID: 30911439.
-
Patel MM, Behar AR, Silasi R, Regmi G, Sansam CL, Keshari RS, Lupu F, Lupu C. Role of ADTRP (Androgen-Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function. J Am Heart Assoc. 2018 11 20; 7(22):e010690.
PMID: 30571485.
Citations:
11 Fields:
Translation:
Animals
-
Keshari RS, Silasi R, Popescu NI, Patel MM, Chaaban H, Lupu C, Coggeshall KM, Mollnes TE, DeMarco SJ, Lupu F. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc Natl Acad Sci U S A. 2017 Aug 01; 114(31):E6390-E6399.
PMID: 28720697.
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs